Ledger.Open graph →
SEC Form D · filed July 15, 2020

Elicio Therapeutics, Inc

Offering
$30.0M
Sold
$6.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Robert Connelly · Cambridge, MAExec · DirectorJulian Adams · Cambridge, MADirectorRobert Ruffolo · Cambridge, MADirectorDaniel Geffken · Cambridge, MAExec · DirectorChristopher Haqq · Cambridge, MAExecJason Burke · Dover, DEExec · DirectorJamie L. Shiller · Dover, DEDirectorJobst T. Klemme · New York, NYDirectorSamon Suwannarat · Grand Cayman, Cayman IslandsExec · DirectorVladimir Ghidirim · Dover, DEExecIsaac Kohlberg · Cambridge, MADirectorGraycliff Capital Partners LLC · Greenville, SCExecGrayBul Tyde GP LLC · Greenville, SCDirectorTaylor Davis · Greenville, SCDirectorFeng H. Xiao · New York, NYExec · DirectorRosemarie H. Fanelli · New York, NYExec · DirectorIsaac Kohlberg · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗